Jan 2017 $5 M No. 7 $2 to $10 million 6
OrthoAccel Technologies, Inc.: Raise no. 7, Jan 2017 × Investors in this round 6 investors had bought by the notice of Jan 20, 2017: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $18 M offered; $13 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $100,000 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeff C. Layton · Executive Officer Kelly C. Enos · Executive Officer Brian R. Smith · Director John C. McCormick · Director Len C. Hedge · Director Todd C. Cooper · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kelly Enos, Chief Financial Officer, by Eric Hoffmann, Attorney-in-Fact. Source: SEC Form D, newest notice filed Jan 20, 2017. Read the notice at the SEC .
equity, options SEC Feb 2016 $12 M No. 6 $10 to $50 million 11
OrthoAccel Technologies, Inc.: Raise no. 6, Feb 2016 × Investors in this round 11 investors had bought by the notice of May 12, 2016: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $12 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeff C. Layton · Executive Officer Kelly C. Enos · Executive Officer Mike K. Lowe · Executive Officer, Director Brian R. Smith · Director John C. McCormick · Director Len C. Hedge · Director Todd C. Cooper · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kelly Enos, Chief Financial Officer, by Eunice Song, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed May 12, 2016. Read the notice at the SEC .
equity SEC Nov 2014 $5 M No. 5 $2 to $10 million 20
OrthoAccel Technologies, Inc.: Raise no. 5, Nov 2014 × Investors in this round 20 investors had bought by the notice of Dec 22, 2014: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeff C. Layton · Executive Officer Kelly C. Enos · Executive Officer Michael K Lowe · Executive Officer, Director Brian R. Smith · Director John C. McCormick · Director Todd C. Cooper · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kelly Enos, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D, newest notice filed Dec 22, 2014. Read the notice at the SEC .
equity SEC Jan 2014 $5 M No. 4 $2 to $10 million 18
OrthoAccel Technologies, Inc.: Raise no. 4, Jan 2014 × Investors in this round 18 investors had bought by the notice of Jan 23, 2014: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeff C. Layton · Executive Officer Michael K. Lowe · Executive Officer, Director Pamela C. Westbrook · Executive Officer Bill C. Ryan · Director Brian R. Smith · Director John C. McCormick · Director Todd C. Cooper · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Pamela Westbrook, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D, newest notice filed Jan 23, 2014. Read the notice at the SEC .
equity SEC Apr 2012 $13 M No. 3 $10 to $50 million 18
OrthoAccel Technologies, Inc.: Raise no. 3, Apr 2012 × Investors in this round 18 investors had bought by the notice of May 29, 2013: 18 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered
Smallest investment taken $750
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael K. Lowe · Executive Officer, Director Pamela C. Westbrook · Executive Officer Bill C. Ryan · Director Brian R. Smith · Director John C. McCormick · Director Todd C. Cooper · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Pamela Westbrook, Chief Financial Officer, by Channah Rose, Attorney-in-Fact. Source: SEC Form D and 1 amendment, newest notice filed May 29, 2013. Read the notice at the SEC .
equity SEC Jul 2010 $5 M No. 2 $2 to $10 million 29
OrthoAccel Technologies, Inc.: Raise no. 2, Jul 2010 × Investors in this round 29 investors had bought by the notice of Aug 30, 2010: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered; $1 M still to sell
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Michael K. Lowe · Executive Officer, Director Pamela R. Westbrook · Executive Officer Brian R. Smith · Director Linda B. Spain · Director Steve R. Banks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds used for working capital including ordinary course executive compensation.”Signed by Michael K. Lowe, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Aug 30, 2010. Read the notice at the SEC .
equity SEC Jul 2009 $2 M No. 1 $2 to $10 million 14
OrthoAccel Technologies, Inc.: Raise no. 1, Jul 2009 × Investors in this round 14 investors had bought by the notice of Dec 22, 2009: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $1
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Michael K. Lowe · Executive Officer Brian K. Smith · Director Linda K. Spain · Director Steve K. Banks · Director William K. Bryan · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Proceeds will be used for working capital, including ordinary course salaries of management.”Signed by Michael K. Lowe, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Dec 22, 2009. Read the notice at the SEC .
debt, options SEC